High-capacity adenoviral vectors for gene transfer and somatic gene therapy

被引：136
作者：
Kochanek, S [1 ]
机构：
[1] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany
来源：
HUMAN GENE THERAPY | 1999年 / 10卷 / 15期
关键词：
D O I：
10.1089/10430349950016807
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The availability of efficient and nontoxic gene delivery technologies is fundamental to the translation of therapeutic concepts into clinical practice by gene transfer. High-capacity adenoviral (HC-Ad) vectors are characterized by the ability to transduce cells in vitro and in vivo with more than 30 kb of nonviral DNA, This quality allows simultaneous gene transfer of several expression cassettes, large promoters, and some genes in their natural genomic context. Because all viral coding sequences are removed from these vectors, safety is considerably improved compared with previous-generation adenoviral vectors.
引用
收藏
页码：2451 / 2459
页数：9
相关论文
共 65 条
[1]   Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations [J].
Alemany, R ;
Dai, YF ;
Lou, YC ;
Sethi, E ;
Prokopenko, E ;
Josephs, SF ;
Zhang, WW .
JOURNAL OF VIROLOGICAL METHODS, 1997, 68 (02) :147-159
[2]  
BERKNER KL, 1988, BIOTECHNIQUES, V6, P616
[3]   Adenovirus-mediated regulable target gene expression in vivo [J].
Burcin, MM ;
Schiedner, G ;
Kochanek, S ;
Tsai, SY ;
O'Malley, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :355-360
[4]   DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle [J].
Chen, HH ;
Mack, LM ;
Choi, SY ;
Ontell, M ;
Kochanek, S ;
Clemens, PR .
HUMAN GENE THERAPY, 1999, 10 (03) :365-373
[5]   Persistence in muscle of an adenoviral vector that lacks all viral genes [J].
Chen, HH ;
Mack, LM ;
Kelly, R ;
Ontell, M ;
Kochanek, S ;
Clemens, PR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1645-1650
[6]   Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre [J].
Chen, LN ;
Anton, M ;
Graham, FL .
SOMATIC CELL AND MOLECULAR GENETICS, 1996, 22 (06) :477-488
[7]  
Clemens PR, 1996, GENE THER, V3, P965
[8]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[9]   GENOME STRUCTURE OF INCOMPLETE PARTICLES OF ADENOVIRUS [J].
DANIELL, E .
JOURNAL OF VIROLOGY, 1976, 19 (02) :685-708
[10]   AN UNUSUAL SYMMETRIC RECOMBINANT BETWEEN ADENOVIRUS-TYPE-12 DNA AND HUMAN CELL-DNA [J].
DEURING, R ;
KLOTZ, G ;
DOERFLER, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (05) :3142-3146
1234567